Insider Trading - Woiwode Thomas

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Woiwode Thomas
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-12-30
Purchase
2021-01-04
6:02 pm
Gritstone Oncology Inc. GRTS Woiwode Thomas
Director
1,347,709 $3.71 $5,000,000 4,450,638
(Indirect)
View
2020-10-20
Purchase
2020-10-20
5:00 pm
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
200,000 $15 $3,000,000 862,444
(Indirect)
View
2020-03-03
Purchase
2020-03-03
7:03 pm
Passage BIO Inc. PASG Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Woiwode Thomas
10% Owner
225,000 $18 $4,050,000 4,959,769
(Indirect
Direct)
View
2020-03-03
Purchase
2020-03-03
6:57 pm
Passage BIO Inc. PASG Woiwode Thomas
Director
10% Owner
225,000 $18 $4,050,000 933,352
(Indirect)
View
2018-05-15
Sale
2018-05-17
5:11 pm
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
44,000 $57.99 $2,551,440 645,643
(Indirect
Direct)
View
2018-05-07
Sale
2018-05-09
5:15 pm
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
121,362 $50.39 $6,115,873 96,359
(Indirect
Direct)
View
2018-04-30
Sale
2018-05-02
6:00 pm
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
30,566 $50.29 $1,537,138 106,018
(Indirect
Direct)
View
2018-04-26
Sale
2018-04-30
8:57 pm
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
222,258 $50.11 $11,136,437 100,780
(Indirect)
View
2018-04-24
Sale
2018-04-26
5:01 pm
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
22,841 $50.99 $1,164,655 115,645
(Indirect)
View
2018-04-20
Sale
2018-04-24
7:42 pm
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
101,994 $50.68 $5,168,901 812,614
(Indirect
Direct)
View
2017-12-22
Sale
2017-12-27
4:14 pm
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
3,059 $20.29 $62,070 4,959
(Direct)
View
2017-11-24
Sale
2017-11-28
4:11 pm
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
1,900 $20.21 $38,406 8,018
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-07-01(A)
Option Award
2021-09-20
8:13 pm
N/A
2031-06-30
Tempest Therapeutics Inc. TPST Woiwode Thomas
Director
6,635 $0 6,635
(Direct)
View
2021-08-25
Other
2021-08-27
5:49 pm
N/A
N/A
Gritstone bio Inc. GRTS Woiwode Thomas
Director
458,152 $0 3,574,489
(Indirect)
View
2021-07-01
Option Award
2021-07-06
6:01 pm
N/A
2031-06-30
Tempest Therapeutics Inc. TPST Woiwode Thomas
Director
10% Owner
6,635 $0 6,635
(Direct)
View
2021-06-25
Option Award
2021-06-29
9:54 pm
N/A
N/A
Millendo Therapeutics Inc. TPST Woiwode Thomas
Director
10% Owner
2,176,411 $0 7,377
(Indirect)
View
2021-06-17
Option Award
2021-06-17
5:14 pm
N/A
2031-06-17
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
15,000 $0 15,000
(Direct)
View
2021-06-11
Other
2021-06-15
4:43 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
506,307 $0 1,391,305
(Indirect)
View
2021-05-27
Option Award
2021-05-28
6:06 pm
N/A
2031-05-26
Passage BIO Inc. PASG Woiwode Thomas
Director
10% Owner
16,918 $0 16,918
(Direct)
View
2021-05-12
Option Award
2021-05-14
8:05 pm
N/A
2031-05-11
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
40,000 $0 40,000
(Direct)
View
2021-04-26
Other
2021-04-28
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
506,310 $0 1,389,085
(Indirect)
View
2020-12-14
Other
2020-12-16
5:10 pm
N/A
N/A
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
12,783 $0 31,605
(Direct)
View
2020-10-20
Conversion
2020-10-20
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
3,092,339 $0 862,444
(Indirect)
View
2020-10-15
Ownership
2020-10-15
5:17 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
0 $0 3,092,339
(Indirect)
View
2020-06-23
Option Award
2020-06-25
5:45 pm
N/A
2030-06-22
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
30,000 $0 30,000
(Direct)
View
2020-06-18
Option Award
2020-06-22
5:40 pm
N/A
2030-06-18
Gritstone Oncology Inc. GRTS Woiwode Thomas
Director
10% Owner
12,500 $0 12,500
(Direct)
View
2020-03-03
Conversion
2020-03-03
7:03 pm
N/A
N/A
Passage BIO Inc. PASG Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Woiwode Thomas
10% Owner
4,734,769 $0 4,959,769
(Direct)
View
2020-03-03
Conversion
2020-03-03
6:57 pm
N/A
N/A
Passage BIO Inc. PASG Woiwode Thomas
Director
10% Owner
4,734,769 $0 933,352
(Indirect)
View
2020-02-27
Option Award
2020-03-02
6:01 pm
N/A
2030-02-27
Passage BIO Inc. PASG Woiwode Thomas
Director
10% Owner
33,836 $0 33,836
(Direct)
View
2020-02-27
Ownership
2020-02-27
8:07 pm
N/A
N/A
Passage BIO Inc. PASG Versant Venture Capital VI L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Versant Vantage I L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Woiwode Thomas
10% Owner
0 $0 4,734,769
(Direct)
View
2020-02-27
Ownership
2020-02-27
7:57 pm
N/A
N/A
Passage BIO Inc. PASG Woiwode Thomas
Director
10% Owner
0 $0 4,734,769
(Indirect)
View
2019-07-31
Option Award
2019-08-02
4:25 pm
N/A
2029-07-30
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
45,000 $0 45,000
(Direct)
View
2019-06-19
Option Award
2019-06-20
4:17 pm
N/A
2029-06-19
Gritstone Oncology Inc. GRTS Woiwode Thomas
Director
10% Owner
8,570 $0 8,570
(Direct)
View
2018-10-02
Conversion
2018-10-02
5:29 pm
N/A
N/A
Gritstone Oncology Inc. GRTS Woiwode Thomas
Director
10% Owner
6,205,858 $0 3,102,929
(Indirect)
View
2018-09-27
Ownership
2018-09-27
5:26 pm
N/A
N/A
Gritstone Oncology Inc. GRTS Woiwode Thomas
Director
10% Owner
0 $0 3,102,929
(Indirect)
View
2018-06-15
Option Award
2018-06-15
9:39 pm
N/A
2028-06-15
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
30,000 $0 30,000
(Indirect)
View
2018-05-31
Option Award
2018-06-15
4:27 pm
N/A
2028-05-30
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
35,000 $0 35,000
(Direct)
View
2018-04-20
Other
2018-04-24
7:42 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
595,241 $0 812,614
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
2,624,075 $0 2,945,045
(Indirect)
View
2017-06-12
Option Award
2017-06-14
7:11 pm
2018-06-12
2027-06-11
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
56,329 $0 103,982
(Direct)
View
2017-05-31
Option Award
2017-06-02
4:30 pm
N/A
2027-05-31
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
30,000 $0 30,000
(Indirect)
View
2017-04-28
Option Award
2017-05-01
8:20 pm
N/A
N/A
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
2,223 $0 47,653
(Direct)
View
2017-03-31
Option Award
2017-04-03
5:57 pm
N/A
N/A
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
3,704 $0 45,430
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, Next